VANTABIOHealthcare Research, Analytics & Technology
Vanta Bioscience Ltd — Balance Sheet
₹15.15
-10.72%
Vanta Bioscience Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 0.63 Cr | 0.63 Cr | 0.63 Cr | 0.63 Cr | — |
| Share Issued | 0.63 Cr | 0.63 Cr | 0.63 Cr | 0.63 Cr | — |
| Net Debt | 69.86 Cr | 60.96 Cr | 57.06 Cr | 44.64 Cr | — |
| Total Debt | 70.08 Cr | 61.12 Cr | 57.16 Cr | 44.87 Cr | — |
| Tangible Book Value | -34.58 Cr | -23.08 Cr | -17.08 Cr | -3.27 Cr | — |
| Invested Capital | 80.51 Cr | 76.31 Cr | 74.68 Cr | 68.87 Cr | — |
| Working Capital | -11.21 Cr | -5.72 Cr | -2.50 Cr | 0.22 Cr | — |
| Net Tangible Assets | -34.58 Cr | -23.08 Cr | -17.08 Cr | -3.27 Cr | — |
| Common Stock Equity | 10.42 Cr | 15.20 Cr | 17.51 Cr | 24.01 Cr | — |
| Total Capitalization | 64.55 Cr | 64.00 Cr | 64.58 Cr | 61.00 Cr | — |
| Total Equity Gross Minority Interest | 3.78 Cr | 12.97 Cr | 18.93 Cr | 29.34 Cr | — |
| Minority Interest | -6.64 Cr | -2.23 Cr | 1.41 Cr | 5.34 Cr | — |
| Stockholders Equity | 10.42 Cr | 15.20 Cr | 17.51 Cr | 24.01 Cr | — |
| Capital Stock | 6.31 Cr | 6.31 Cr | 6.31 Cr | 6.31 Cr | — |
| Common Stock | 6.31 Cr | 6.31 Cr | 6.31 Cr | 6.31 Cr | — |
| Total Liabilities Net Minority Interest | 82.10 Cr | 72.42 Cr | 65.78 Cr | 52.06 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 55.53 Cr | 49.55 Cr | 48.03 Cr | 37.78 Cr | — |
| Non Current Deferred Taxes Liabilities | 1.41 Cr | 0.75 Cr | 0.97 Cr | 0.78 Cr | — |
| Long Term Debt And Capital Lease Obligation | 54.13 Cr | 48.80 Cr | 47.07 Cr | 37.00 Cr | — |
| Long Term Debt | 54.13 Cr | 48.80 Cr | 47.07 Cr | 37.00 Cr | — |
| Current Liabilities | 26.56 Cr | 22.88 Cr | 17.75 Cr | 14.28 Cr | — |
| Other Current Liabilities | 5.66 Cr | 0.95 Cr | 0.56 Cr | 0.62 Cr | — |
| Current Debt And Capital Lease Obligation | 15.96 Cr | 12.31 Cr | 10.09 Cr | 7.87 Cr | — |
| Current Debt | 15.96 Cr | 12.31 Cr | 10.09 Cr | 7.87 Cr | — |
| Payables | 4.94 Cr | 9.61 Cr | 7.10 Cr | 5.75 Cr | — |
| Total Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Payable | 4.94 Cr | 5.57 Cr | 4.22 Cr | 2.46 Cr | — |
| Total Assets | 85.88 Cr | 85.40 Cr | 84.71 Cr | 81.40 Cr | — |
| Total Non Current Assets | 70.52 Cr | 68.24 Cr | 69.47 Cr | 66.91 Cr | — |
| Other Non Current Assets | 1.56 Cr | 2000.00 | -20.00 | 2.32 Cr | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentin Financial Assets | 0.00 | 0.91 Cr | 0.91 Cr | 1.42 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentsin Associatesat Cost | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investmentsin Subsidiariesat Cost | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 45.00 Cr | 38.28 Cr | 34.60 Cr | 27.27 Cr | — |
| Other Intangible Assets | 45.00 Cr | 38.28 Cr | 34.60 Cr | 27.27 Cr | — |
| Net PPE | 23.96 Cr | 28.41 Cr | 33.23 Cr | 37.32 Cr | — |
| Gross PPE | 23.96 Cr | 42.95 Cr | 43.04 Cr | 37.32 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 22.78 Cr | — |
| Other Properties | 23.96 Cr | 19.69 Cr | 19.73 Cr | 14.54 Cr | — |
| Current Assets | 15.36 Cr | 17.16 Cr | 15.24 Cr | 14.50 Cr | — |
| Other Current Assets | 0.50 Cr | 0.56 Cr | -30.00 | 0.72 Cr | — |
| Inventory | 6.51 Cr | 7.52 Cr | 7.16 Cr | 7.24 Cr | — |
| Other Receivables | 5.63 Cr | 0.16 Cr | 0.11 Cr | 0.08 Cr | — |
| Taxes Receivable | 0.00 | 4.42 Cr | 4.19 Cr | 4.10 Cr | — |
| Accounts Receivable | 2.50 Cr | 3.14 Cr | 1.96 Cr | 1.13 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.22 Cr | 0.16 Cr | 0.10 Cr | 0.22 Cr | — |
| Cash And Cash Equivalents | 0.22 Cr | 0.16 Cr | 0.10 Cr | 0.22 Cr | — |
| Retained Earnings | — | -6.33 Cr | -4.01 Cr | 2.48 Cr | 2.39 Cr |
| Additional Paid In Capital | — | 15.21 Cr | 15.21 Cr | 15.21 Cr | 15.21 Cr |
| Other Non Current Liabilities | — | -2000.00 | -10.00 | — | -10.00 |
| Current Deferred Taxes Liabilities | — | 0.00 | 0.00 | 0.04 Cr | 0.06 Cr |
| Other Payable | — | 4.04 Cr | 2.88 Cr | 3.29 Cr | 2.30 Cr |
| Non Current Prepaid Assets | — | 0.64 Cr | 0.73 Cr | 0.90 Cr | 0.97 Cr |
| Available For Sale Securities | — | 0.91 Cr | 0.91 Cr | 1.42 Cr | — |
| Accumulated Depreciation | — | -14.54 Cr | -9.81 Cr | -5.04 Cr | -3.72 Cr |
| Machinery Furniture Equipment | — | 12.11 Cr | 12.16 Cr | 3.38 Cr | 5.30 Cr |
| Buildings And Improvements | — | 9.97 Cr | 9.97 Cr | 5.10 Cr | 6.00 Cr |
| Land And Improvements | — | 1.18 Cr | 1.18 Cr | 1.18 Cr | 1.18 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 1.76 Cr | 1.73 Cr | 1.72 Cr | 1.51 Cr |
| Work In Process | — | 7.45 Cr | 7.07 Cr | 7.18 Cr | 9.72 Cr |
| Raw Materials | — | 0.07 Cr | 0.09 Cr | 0.05 Cr | 0.04 Cr |
| Cash Financial | — | 0.16 Cr | 0.10 Cr | 0.22 Cr | 2.65 Cr |
| Current Provisions | — | — | — | 0.04 Cr | 0.06 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vanta Bioscience Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.